Status:

RECRUITING

The Family Perspectives Project Pilot Trial

Lead Sponsor:

Matthew Modes

Collaborating Sponsors:

National Palliative Care Research Center

Conditions:

Respiratory Failure

Family Support

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of the study is to conduct a pilot randomized trial of a program designed to enhance equitable communication and emotional support for families of critically ill patients in order to deter...

Eligibility Criteria

Inclusion

  • Patient inclusion criteria:
  • Individuals 18 years old or older.
  • Individuals admitted to the medical intensive care unit (MICU) at Cedars-Sinai Medical Center.
  • Individuals with acute respiratory failure, defined as \>24 hours of invasive mechanical ventilation.
  • Individuals who received invasive mechanical ventilation within 24 hours of admission to the MICU.
  • Individuals expected to need invasive mechanical ventilation for \>72 hours total, as determined by the patient's intensivist physician (fellow or attending).
  • Primary surrogate decision maker inclusion criteria:
  • o Individuals 18 years old or older.
  • Individual who self-identifies as the most responsible for making decisions for the enrolled patient (can be either family member or close friend).
  • Proficiency in English language.
  • ICU support counselor inclusion criteria:
  • Individuals 18 years old or older.
  • Individuals who work as hospital chaplains in the MICU.
  • Physician (intensivist) inclusion criteria:
  • Individuals 18 years old or older.
  • Individuals who work as critical care physicians in the MICU (fellow or attending).
  • Nurse inclusion criteria:
  • Individuals 18 years old or older.
  • Individuals who work as bedside nurses in the MICU.
  • Social worker inclusion criteria:
  • Individuals 18 years old or older.
  • Individuals work as social workers in the MICU.

Exclusion

  • Patient exclusion criteria:
  • o Any records flagged "break the glass" or "research opt out."
  • o Individuals expected to die within 24 hours of potential enrollment, as determined by the patient's intensivist physician (fellow or attending).
  • o Individuals on comfort care protocol or with clear preference for comfort care, as determined by the patient's intensivist physician (fellow or attending).
  • Individuals who are chronically dependent on a ventilator prior to admission.
  • Individuals with acute on chronic neuromuscular disease-related respiratory failure (e.g., Guillain Barre, Muscular Dystrophy, Myasthenia Gravis, etc.).
  • Individuals imminently awaiting organ transplant, as determined by the patient's intensivist physician (fellow or attending).
  • Individuals with decisional capacity, as determined by the patient's intensivist physician (fellow or attending).
  • Individuals who are unrepresented (i.e., patient has no surrogate decision maker).
  • Individuals whose potential enrolled family member (primary surrogate decision maker) is not proficient in English.
  • Individuals whose attending physician is the PI on this study at the time of potential enrollment.
  • Individuals who are cared for by intensivist physicians (fellow and attending) who do not agree to participate in the study.
  • Individuals who have a pre-existing relationship with a hospital chaplain who does not agree to participate in the study, as determined by that chaplain.
  • Primary surrogate decision maker exclusion criteria:
  • o Not proficient in English language. (Rationale: materials and intervention are not adapted in other languages.)
  • ICU support counselor exclusion criteria:
  • o None
  • Physician (intensivist) exclusion criteria:
  • o None
  • Nurse exclusion criteria:
  • o None
  • Social worker exclusion criteria:
  • None

Key Trial Info

Start Date :

October 13 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 1 2026

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT06039501

Start Date

October 13 2023

End Date

October 1 2026

Last Update

June 15 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Cedars-Sinai Medical Center

Los Angeles, California, United States, 90048